West Announces Second-Quarter 2018 Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. FIX
7. BE
8. TSCO
9. WCN
10. NDAQ

Go back to West Announces Second-Quarter 2018 Results

West Pharma (WST) Tops Q2 EPS by 3c, Revenues Beat; Reaffirms FY Guidance

July 26, 2018 6:11 AM EDT

West Pharma (NYSE: WST) reported Q2 EPS of $0.70, $0.03 better than the analyst estimate of $0.67. Revenue for the quarter came in at $447.5 million versus the consensus estimate of $424.49 million.

Executive Summary

Second-quarter 2018 reported net sales of $447.5 million grew 12.6% over the prior-year quarter. At constant currency, organic sales growth was 9.0%.Second-quarter 2018 reported-diluted EPS was $0.75, as compared to $0.51 in the same period last year. Excluding restructuring charges and a non-recurring tax benefit, second-quarter 2018 adjusted-diluted EPS was $0.70, as compared to adjusted-diluted EPS of $0.66 in the same period last year.The Company reaffirms full-year 2018 net sales guidance... More